Chlorogenic acid was found to reduce cell proliferation by attenuation of the CDK19/YAP/O-GlcNAcylation pathway in liver cancer, indicating that chlorogenic acid could serve as a compound for treating diabetes-associated liver cancer [101]. Here, YAP1 is linked to liver cancer.